Skip to main content
    G

    Genprex Inc (GNPX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.90
    -0.18 (-8.65%)

    Market Cap: $1.71M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Genprex Inc (GNPX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Genprex are XORTX Therapeutics (XRTX), Enlivex Therapeutics (ENLV) and Kairos Pharma (KAPA). By market cap, Genprex ranks 12th of the 13 companies on this page; Traws Pharma (TRAW) is the largest at $3.86M.

    Peer Comparison

    GNPX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Genprex (GNPX)$1.71MN/AN/A0.0%N/A0.0%0.00%
    XORTX Therapeutics Inc (XRTX)$2.00MN/AN/A0.0%N/A0.0%0.00%
    Enlivex Therapeutics Ltd (ENLV)$1.82MN/AN/A0.0%-0.3%0.0%0.00%
    Kairos Pharma, Ltd. (KAPA)$1.54MN/AN/A0.0%N/A0.0%0.00%
    Jupiter Neurosciences, Inc. Common Stock (JUNS)$2.32MN/A21.0x0.0%1154.5%0.0%0.00%
    Onconetix Inc (ONCO)$2.15MN/A1.0x0.0%N/A-83.9%0.00%
    Purple Biotech (PPBT)$2.65MN/AN/A0.0%-156.2%0.0%0.00%
    Revelation Biosciences Inc (REVB)$2.43MN/AN/A0.0%N/A0.0%0.00%
    Curis Inc (CRIS)$2.97MN/A1.6x0.0%N/A-66.0%0.00%
    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)$1.82MN/A1.7x0.0%N/A-32.5%0.00%
    Traws Pharma Inc (TRAW)$3.86MN/AN/A0.0%N/A-100.0%0.00%
    BioRestorative Therapies Inc (BRTX)$2.06MN/A70.3x0.0%-289.9%-7.3%0.00%
    Mustang Bio Inc (MBIO)$3.20MN/AN/A0.0%N/A0.0%0.00%
    Peer median$2.24MN/A1.7x0.0%-78.2%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Genprex, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    XORTX Therapeutics Inc (XRTX)
    XORTX Therapeutics Inc., a biopharmaceutical company, is dedicated to the development and commercialization of therapies to treat progressive kidney disease...
    XRTX competitors
    Enlivex Therapeutics Ltd (ENLV)
    Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel.
    ENLV competitors
    Kairos Pharma, Ltd. (KAPA)
    Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients.
    KAPA competitors
    Jupiter Neurosciences, Inc. Common Stock (JUNS)
    Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company...
    JUNS competitors
    Onconetix Inc (ONCO)
    Onconetix Inc. is a cutting-edge biotechnology firm committed to revolutionizing cancer care with its innovative diagnostic and therapeutic solutions.
    ONCO competitors
    Purple Biotech (PPBT)
    Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United...
    PPBT competitors
    Revelation Biosciences Inc (REVB)
    Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics...
    REVB competitors
    Curis Inc (CRIS)
    Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States.
    CRIS competitors
    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)
    60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention...
    SXTP competitors
    Traws Pharma Inc (TRAW)
    Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States.
    TRAW competitors
    BioRestorative Therapies Inc (BRTX)
    BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue...
    BRTX competitors
    Mustang Bio Inc (MBIO)
    Mustang Bio, Inc., a clinical-stage biopharmaceutical company, is focused on translating medical advances in cell and gene therapies into potential cures...
    MBIO competitors

    Frequently Asked Questions About GNPX

    Who are Genprex's main competitors?

    The companies most similar to Genprex include XORTX Therapeutics (XRTX), Enlivex Therapeutics (ENLV), Kairos Pharma (KAPA), Jupiter Neurosciences, Inc. Common Stock (JUNS) and Onconetix (ONCO), listed from the closest match.

    Who is Genprex's biggest competitor?

    Traws Pharma (TRAW) is the largest of the similar companies at $3.86M; XORTX Therapeutics (XRTX) is the closest match by business profile, size, sector and industry.

    How does GNPX stock compare with its competitors?

    GNPX's net margin is 0.0% against a peer median of 0.0%.

    Which of Genprex's competitors pays a higher dividend?

    Genprex pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Genprex bigger than its competitors?

    No. Genprex is 12th by market cap among the 13 companies on this page; the largest is Traws Pharma (TRAW) at $3.86M.